News & Views

Invest in Hope for Nursing’s Future During Oncology Nursing Foundation’s 40th Anniversary

As we pass the one-year mark of the COVID-19 coronavirus pandemic and reflect on all that has ensued since last March, human nature is to focus on our losses. By all accounts, 2020 has been a difficult period in our personal, professional, and civic lives. All of us grieve for our loved ones, patients, and the freedoms of life we have sacrificed.

Trending Topics

View All Topics

$FDA Grants Accelerated Approval to Melphalan Flufenamide for Relapsed or Refractory Multiple Myeloma$

Clinical practice

FDA Grants Accelerated Approval to Melphalan Flufenamide for Relapsed or Refractory Multiple Myeloma

Self-Care Is Essential When Working Remotely

Nurse well-being

Self-Care Is Essential When Working Remotely

February 25, 2021

Medicaid Expansion Coincides With Earlier Colon Cancer Diagnosis Rates

Medicaid Expansion Coincides With Earlier Colon Cancer Diagnosis Rates

February 24, 2021

FDA Approves Cemiplimab-Rwlc for NSCLC With High PD-L1 Expression

Clinical practice

FDA Approves Cemiplimab-Rwlc for NSCLC With High PD-L1 Expression

February 23, 2021

Be Alert for Axillary Adenopathy After COVID-19 Vaccination

Be Alert for Axillary Adenopathy After COVID-19 Vaccination

February 19, 2021

CMS Changes to Medicare Prescription Coverage Could Affect Patient Care

Access to cancer care

CMS Changes to Medicare Prescription Coverage Could Affect Patient Care

February 18, 2021

Mortality Rates After Cancer Surgery Decrease, but Racial Disparities Remain

Mortality Rates After Cancer Surgery Decrease, but Racial Disparities Remain

February 17, 2021

COVID-19’s Implications for People With Cancer and Oncology Nurses

COVID-19’s Implications for People With Cancer and Oncology Nurses

February 16, 2021

FDA Approves Trilaciclib to Reduce Chemotherapy-Induced Myelosuppression

FDA Approves Trilaciclib to Reduce Chemotherapy-Induced Myelosuppression

February 15, 2021

Inclusion in National Repository Helps Move ONS Guidelines™ Evidence to Practice

Clinical practice guidelines

Inclusion in National Repository Helps Move ONS Guidelines™ Evidence to Practice

February 15, 2021

The Case of the Sensitive Staging System

Survivorship care plans

The Case of the Sensitive Staging System

February 15, 2021

ONS Past President Mary Gullatte, PhD, RN, ANP-BC, AOCN®, LSSYB, FAAN

ONS’s First African American President Shares Insights and Advice in Honor of Black History Month

February 15, 2021

How to Manage Survivor Guilt During a Pandemic

Patient Support

How to Manage Survivor Guilt During a Pandemic

February 11, 2021

FDA Approves Cemiplimab-Rwlc for Locally Advanced and Metastatic Basal Cell Carcinoma

U.S. Food and Drug Administration (FDA)

FDA Approves Cemiplimab-Rwlc for Locally Advanced and Metastatic Basal Cell Carcinoma

February 10, 2021

Targeted Radiation Reduces Pain From Spine Metastasis

Targeted Radiation Reduces Pain From Spine Metastasis

February 10, 2021

$FDA Approves Lisocabtagene Maraleucel for Relapsed or Refractory Large B-Cell Lymphoma$

U.S. Food and Drug Administration (FDA)

FDA Approves Lisocabtagene Maraleucel for Relapsed or Refractory Large B-Cell Lymphoma

February 10, 2021

How Can Oncology Nurses Reduce Isolation for Caregivers?

How Can Oncology Nurses Reduce Isolation for Caregivers?

February 09, 2021

Pandemics Have Serious Psychological Implications for Nurses

Nurse well-being

Pandemics Have Serious Psychological Implications for Nurses

February 09, 2021

FDA Grants Accelerated Approval to Umbralisib for Marginal Zone and Follicular Lymphoma

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Umbralisib for Marginal Zone and Follicular Lymphoma

February 08, 2021

ONS Board Wraps Up 2020 With Leadership Planning

ONS board of directors

ONS Board Wraps Up 2020 With Leadership Planning

February 08, 2021

Nursing Considerations for Lymphoma Survivorship Care

Nursing Considerations for Lymphoma Survivorship Care

February 04, 2021

FDA Grants Accelerated Approval to Tepotinib for Metastatic NSCLC

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Tepotinib for Metastatic NSCLC

February 03, 2021

Even Short Treatment Delays Affect Cancer Outcomes

Even Short Treatment Delays Affect Cancer Outcomes

February 03, 2021

Cancer Support Groups Help Patients Develop Critical Connections

Patient Support

Cancer Support Groups Help Patients Develop Critical Connections

February 02, 2021

Social Isolation in Patients With Cancer

Patient empowerment

Being Apart Doesn’t Mean Fighting Cancer Alone

February 02, 2021

Leadership Is the Foundational Competency for Oncology Nursing in 2029

Leadership Is the Foundational Competency for Oncology Nursing in 2029

February 01, 2021

Nursing Considerations for Breast Cancer Survivorship Care

Nursing Considerations for Breast Cancer Survivorship Care

January 28, 2021

First-Time Smoking Age Increases Among Young Adults

First-Time Smoking Age Increases Among Young Adults

January 27, 2021

Oncology Drug Reference Sheet: Tafasitamab-Cxix

Oncology drug research

Oncology Drug Reference Sheet: Tafasitamab-Cxix

January 26, 2021

Meet Your ONS Leader: Darcy Burbage

Meet Your ONS Leader: Darcy Burbage

January 25, 2021

Genetic Disorder Reference Sheet: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)

Genetics & genomics

Genetic Disorder Reference Sheet: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)

January 25, 2021

FDA Approves Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma

Cancer treatments

FDA Approves Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma

January 25, 2021

How Can Innovation and Opportunity Guide a Career in Nursing Research?

How Can Innovation and Opportunity Guide a Career in Nursing Research?

January 20, 2021

The Case of the Targeted Therapy Toxicities

Clinical practice

The Case of the Targeted Therapy Toxicities

January 19, 2021

FDA Approves Fam-Trastuzumab Deruxtecan-Dxki for HER2-Positive Gastric Adenocarcinomas

Cancer treatments

FDA Approves Fam-Trastuzumab Deruxtecan-Dxki for HER2-Positive Gastric Adenocarcinomas

January 19, 2021

Lifelong Learning and Professional Development Are Crucial to Patient Outcomes

nursing professional development

Lifelong Learning and Professional Development Are Crucial to Patient Outcomes

January 18, 2021

What the Evidence Says for Guided Imagery in Oncologic Care

Complementary therapy

What the Evidence Says for Guided Imagery in Oncologic Care

January 18, 2021

$FDA Approves Crizotinib for Children and Young Adults With Relapsed or Refractory, Systemic ALK-Positive Anaplastic Large Cell Lymphoma$

Cancer treatments

FDA Approves Crizotinib for Children and Young Adults With Relapsed or Refractory, Systemic ALK-Positive Anaplastic Large Cell Lymphoma

January 15, 2021

Nurses Break Record as Most Trusted Profession for 19 Years Running

Oncology nursing community

Nurses Break Record as Most Trusted Profession for 19 Years Running

January 15, 2021

How to Accept Criticism With Class

Interprofessional issues

How to Accept Criticism With Class

January 14, 2021

Genomics Provides Insight on Exceptionally Responding Patients

Genetics & genomics

Genomics Provides Insight on Exceptionally Responding Patients

January 13, 2021

Manage Cancer Treatment-Related Radiodermatitis With ONS Guidelines™

Clinical practice guidelines

Manage Cancer Treatment-Related Radiodermatitis With ONS Guidelines™

January 12, 2021

ONS Enterprise Plans for the Future of Cancer Care

ONS Enterprise Plans for the Future of Cancer Care

January 11, 2021

How Does Nursing Certification Foster Lifelong Professional Development?

nursing professional development

How Does Nursing Certification Foster Lifelong Professional Development?

January 07, 2021

How COVID-19 May Increase Access to and Reduce Disparities in Cancer Clinical Trials

Cancer research

How COVID-19 May Increase Access to and Reduce Disparities in Cancer Clinical Trials

January 06, 2021

Sunstar Americas, Inc., Expands Voluntary Nationwide Recall of Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12%, for Microbial Contamination

U.S. Food and Drug Administration (FDA)

Sunstar Americas, Inc., Expands Voluntary Nationwide Recall of Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12%, for Microbial Contamination

January 06, 2021

How Enhancing Your Career Benefits Both Your Patients and Yourself

nursing professional development

How Enhancing Your Career Benefits Both Your Patients and Yourself

January 05, 2021

Happy New Year’ Takes On New Meaning for 2021

'Happy New Year’ Takes On New Meaning for 2021

January 04, 2021

Adding Nivolumab to Chemo Improves Survival for Advanced Gastric Cancer

Adding Nivolumab to Chemo Improves Survival for Advanced Gastric Cancer

December 30, 2020

Back to Top ▲